🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthew A. Powell

ORCID: 0000-0002-1968-2772

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.870Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Papers

Driven by 12 papers — median percentile 77. Top paper: “Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors”.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy

Scientific Reports(2022)10.1038/s41598-022-19778-1

N/A

0DataRank · unranked

7 citations

Sitai Kou, Yixiao Lin, Andrea R. Hagemann, Ian S. Hagemann, Premal H. Thaker +7 more

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101060

N/A

0DataRank · unranked

3 citations

Sophia Lewis, Mark C. Valentine, M. Palisoul, Premal H. Thaker, Andrea R. Hagemann +6 more

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

BMC Cancer(2022)10.1186/s12885-022-09367-w

N/A

0DataRank · unranked

4 citations

Yassar M. Hashim, J.C. Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong +5 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

Research Square(2022)10.21203/rs.3.rs-1153043/v1

N/A

0DataRank · unranked

0 citations

Yassar M. Hashim, J.C. Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong +5 more

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005303

N/A

0DataRank · unranked

8 citations

Surbhi Grover, Yi Huang, Premal H. Thaker, Lindsay M. Kuroki, Matthew A. Powell +6 more

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.026

N/A

0DataRank · unranked

6 citations

Chunqiao Tian, Jordyn Tumas, Neil T. Phippen, Christopher M. Tarney, Erica Hope +22 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Multi-center, international endometrial cancer consortium highlights

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101805

N/A

0DataRank · unranked

3 citations

Anna Giudici, Vincenzo Tarantino, Stuart A. Ostby, Kelly H. Bruce, Daniel M. Breitkopf +28 more